Journal Studies: Investing Month-to-month
AARP-Branded Medicare Drug Plan Is Too Expensive for Many Retirees, Critics Say
By R, andall Smith
November 4, 2022 at 2:00 PM ET
The favored plan’s worth has risen sharply lately—prompting some specialists to counsel enrollees contemplate switching.
